Clinical Trial Update: FLT-PET Activity Change After Allogeneic Umbilical Cord Blood (UCB) Therapy in Cerebral Palsy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating FLT-PET activity after allogeneic umbilical cord blood therapy in cerebral palsy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy

Drugs mentioned

• Allogeneic Umbilical Cord Blood Therapy

Snippet

Sponsor: Bundang CHA Hospital | Conditions: Cerebral Palsy | Phase 2 | Status: WITHDRAWN